Jasna Maksimoska, Ph.D.
Affiliations: | 2009 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Biological ChemistryGoogle:
"Jasna Maksimoska"Mean distance: 9.66 | S | N | B | C | P |
Parents
Sign in to add mentor| Ronen Marmorstein | grad student | 2009 | Penn | |
| (Development of organometallic compounds as potent protein kinase inhibitors.) | ||||
| Eric Meggers | grad student | 2005-2009 | Penn | |
| (Development of organometallic compounds as potent protein kinase inhibitors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mawhinney MT, Liu R, Lu F, et al. (2018) CTCF-Induced Circular DNA Complexes Observed by Atomic Force Microscopy. Journal of Molecular Biology |
| Grasso M, Estrada MA, Ventocilla C, et al. (2016) Chemically Linked Vemurafenib Inhibitors Promote an Inactive BRAFV600E Conformation. Acs Chemical Biology |
| Shirakawa K, Wang L, Man N, et al. (2016) Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. Elife. 5 |
| Shirakawa K, Wang L, Man N, et al. (2016) Author response: Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity Elife |
| Ndubaku CO, Crawford JJ, Drobnick J, et al. (2015) Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety. Acs Medicinal Chemistry Letters. 6: 1241-6 |
| Ndubaku CO, Crawford JJ, Drobnick J, et al. (2015) Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pKa Polar Moiety Acs Medicinal Chemistry Letters. 6: 1241-1246 |
| Maksimoska J, Segura-Peña D, Cole PA, et al. (2014) Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues. Biochemistry. 53: 3415-22 |
| Plasschaert RN, Vigneau S, Tempera I, et al. (2014) CTCF binding site sequence differences are associated with unique regulatory and functional trends during embryonic stem cell differentiation. Nucleic Acids Research. 42: 774-89 |
| Plasschaert RN, Vigneau S, Tempera I, et al. (2014) CTCF binding site sequence differences are associated with unique regulatory and functional trends during embryonic stem cell differentiation Nucleic Acids Research. 42: 7487-7487 |
| Licciulli S, Maksimoska J, Zhou C, et al. (2013) FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas. The Journal of Biological Chemistry. 288: 29105-14 |